Trial Design Articles

Applied Clinical Trials: Mar 31, 2015
How the practical application of these methods can help overcome the complex demands of cancer trials.
Applied Clinical Trials: Mar 31, 2015
Successful conduct of hematological malignancy trials requires addressing several unique complexities.
Applied Clinical Trials: Mar 31, 2015
Study shows that industry contributions to R&D go well beyond the applied area of clinical testing.
Applied Clinical Trials: Feb 01, 2015
New study highlights the importance of focusing on non-core procedures to better optimize study design.
Applied Clinical Trials: Feb 01, 2015
Cancer Research UK applies risk-based monitoring across its entire trial portfolio. What were the results?
Applied Clinical Trials: Feb 01, 2015
Examining the design, implementation, and challenges of this direct-to-patient study model.
Applied Clinical Trials: Jan 22, 2015
Over recent years global drug companies large or small have recognized that one root cause of the high failure rate in their clinical development lies in the selection of right therapeutic targets.
Applied Clinical Trials: Jan 19, 2015
Case Study, Trigemina TI-001 for high frequency migraine
Applied Clinical Trials: Dec 01, 2014
Based on nearly 850 responses, a recent CISCRP study finds that the European public considers clinical research to be riskier than does the public in many other global regions.
Applied Clinical Trials: Sep 30, 2014
A systematic approach for early identification of BP effects during development of new drugs.

Trial Design News

YPrime Awarded Global Phase II Oncology Clinical Trial

Throughout this trial, YPrime will be supporting world class selected sites to conduct the study with data driven metrics pulled from these tools. YPrime is dedicated to applying its leading edge eClinical technology to help forward unmet medical needs in the Biotech and Pharmaceutical industry.

Annual ASCO Report Shows Widespread Disturbance in Oncology Practice

A new study by the American Society of Clinical Oncology (ASCO) is now available, which chronicles the current realities of the cancer care system and examines trends in the oncology workforce.

CRF Health's eCOA Solution for Diabetes Trials

CRF Health, the leading global provider of eCOA solutions for the life sciences industry, today announced a complete TrialMax® eCOA solution for diabetes clinical trials.

Intrinsic Imaging Awarded Interventional Medical Device Trial

Intrinsic Imaging is the only imaging core lab that is ISO 13485 certified specifically to provide quality services for medical device clinical trials.

ERT to Acquire PHT Corporation

ERT, a leading global solution provider for high- quality patient safety and efficacy endpoint data collection, and PHT Corporation (PHT), the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research, announced today that they have signed a definitive agreement under which ERT will acquire PHT.